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PCardiac Pacemakers
linical Study of
nterference With Cardiac Pacemakers
y a Magnetic Field at Power Line Frequencies
lexandre Trigano, MD,* Olivier Blandeau, BS,* Martine Souques, MD,† Jean Pierre Gernez, BS,‡
sabelle Magne, PHD‡
arseille, Paris, and Moret-sur-Loing, France
OBJECTIVES This study examined the risk of interference by high magnetic flux density with permanent
pacemakers.
BACKGROUND Several forms of electromagnetic energy may interfere with the functions of implanted
pacemakers. No clinical study has reported specific and relevant information pertaining to
magnetic fields near power lines or electrical appliances.
METHODS A total of 250 consecutive tests were performed in 245 recipients of permanent pacemakers
during 12-lead electrocardiographic monitoring. A dedicated exposure system generated a
50-Hz frequency and maximum 100-T flux density, while the electrical field was kept at
values on the order of 0.10 V/m.
RESULTS A switch to the asynchronous mode was recorded in three patients with devices programmed
in the unipolar sensing configuration. A sustained mode switch was followed by symptomatic
pacing inhibition in one patient. No effect on devices programmed in bipolar sensing was
observed, except for a single interaction with a specific capture monitoring algorithm.
CONCLUSIONS The overall incidence of interaction by a magnetic field was low in patients tested with a wide
variety of conventionally programmed pacemaker models. A magnetic field pulsed at power
frequency can cause a mode switch and pacing inhibition in patients with devices pro-
grammed in the unipolar sensing configuration. The risk of interference appears negligible in
patients with bipolar sensing programming. (J Am Coll Cardiol 2005;45:896–900) © 2005
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.072by the American College of Cardiology Foundation
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blectromagnetic interference (EMI) with implanted pace-
akers has been studied in vitro and in several clinical
tudies or reported from anecdotal daily life observations.
lectromagnetic interference may be observed near high-
oltage power lines and plants, transformers, or other
tructures or may be caused by electrical appliances held
lose to the chest. Although interference by strong electrical
elds has been widely reported, EMI from magnetic fields
as not been studied as intensively. Strong magnetic fields
re present in industrial or occupational environments and
mitted in day-to-day life by household appliances and
ome electronic surveillance articles. The safe limits of
xposure to magnetic flux in recipients of implanted pace-
akers remain to be established. Although simulations
sing a model of the human body have been presented, a
ingle, nondefinitive clinical study has been published on
his subject (1–3).
This study was designed to examine, in a large patient
opulation, the behavior of implanted cardiac pacemakers in
From the *Department of Cardiology, Centre Hospitalier Universitaire Nord,
arseille; †Department of Medical Studies, Electricité de France, EDF-Gaz de
rance, Paris; and ‡Electricité de France Research and Development, Electrical
aboratories, Electromagnetic Compatibility Group, Moret-sur-Loing, France. This
ork was supported by a grant from Le Réseau de Transport de l’Electricité and
lectricité de France, Department of Medical Studies, Paris, France.o
Manuscript received August 22, 2004; revised manuscript received September 19,
004, accepted October 18, 2004.he presence of magnetic fields at power line frequency and
00-T flux density, the value retained at 50 Hz in the
uropean recommendations for general public exposure
1999/519/EC) (4). The objectives were to provide clinical
ata to international organizations responsible for establish-
ng specific limits of exposure for recipients of permanent
acemakers.
ETHODS
atient population. The study design was approved by the
thical Committee for Human Research of La Pitié-
alpétrière Hospital, University of Paris, France. All pa-
ients between 18 and 85 years of age presenting for routine
mbulatory pacemaker follow-up during the study period
ere invited to participate. Written, informed consent was
btained from all patients. Pretesting examination included
12-lead electrocardiogram (ECG), device interrogation,
acing and sensing threshold measurements, exclusion of
yopotential interference, and evaluation of the intrinsic
hythm. The optimal pacing/sensing parameters determined
or each patient were programmed and remained unchanged
uring testing. Pacing dependency was defined as a 2-s
eriod of asystole or an escape rhythm at a rate 40
eats/min during pacing inhibition or during measurement
f the capture threshold.
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March 15, 2005:896–900 Magnetic Field and Cardiac Pacemakersesting protocol. The exposure system consisted of a pair
f rectangular, 120 140 cm, Helmholtz coils, 80 cm apart,
ounted at the level of the patient’s chest. A programmable
ource of alternative current was connected to the coils
model 6530, Chroma, Taipei-Hsien, Taiwan). Under the
ontrol of a computer using a LabView program (National
nstruments, Austin, Texas), the source generated a 50-Hz
agnetic field with a flux density programmable between 0
nd 100 T. The nominal voltage of the circuit was 16 V.
ach coil consisted of 29 wires, 1.53 mm2 in the cross-
ectional area, receiving 5-V tension, generating 3-Amp
urrent. The electrical field between the gates was on the
rder of 0.10 V/m. Three-dimensional calculation of the
ux density with the EFC 400 software (Wandel and
oltermann, Eningen, Germany) confirmed the homoge-
Abbreviations and Acronyms
AVB  atrioventricular block
ECG  electrocardiogram
EMI  electromagnetic interference
igure 1. Exposure of the pacing systems and configuration of the magnetic
y, and vertical Bz axes. A homogeneous 100-T flux density was also measure
n the horizontal plane at Z0 (Helmholtz coils center). The high values correspeity of the magnetic field at the center of the induction
olume (Fig. 1). The flux density, calculated as the total flux
ivided by the cross-sectional area of the volume through
hich it flows, was monitored through the exposure system
y a sensor fixed on one of the gates at the level of the
atient’s chest. The room flux density was measured by a
hree-axial detector placed at a distance of 3 m away from
he system.
No component of the system under tension was exposed,
nd the installation of the exposure system was approved by
he local electrical safety commission. The patients were
nstructed to walk through the system at a normal pace,
nce parallel and once perpendicular to the gates, as well as
tand at least 20 s inside the system. Thus, six exposures,
hree with and three without magnetic field generated, were
andomly assigned to each patient, during each test. During
he test, the time/density of the continuous signal of the
agnetic field in the exposure system was monitored. The
ata collection included the frequency of the signal, voltage
mplitude from the source, root mean square voltage, and
urrent in the coils. The position of the patient, signal
The flux density (T) was calculated along the longitudinal Bx, transversalfield.
d between the gates at the level of the chest. The flux density was shown
ond to the proximity of the coils.
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Magnetic Field and Cardiac Pacemakers March 15, 2005:896–900requency, and flux densities in the room and in the gate
ere recorded every second in an Excel program application
Microsoft Corp., Seattle, Washington). A 12-lead ECG
as continuously monitored using an independent
omputer-based ECG with an optical fiber connection to
uarantee complete insulation of the patient from the
omputer. Attention was paid to select recordings free of
otion or 50-Hz artifacts, which might have precluded a
etailed analysis of the ECG. All tests were performed at a
00-T maximum flux density. The test could be inter-
upted at any time, if necessary, or repeated to study its
eproducibility. In case of interference, the control of the
ux density between 0 and 100 T was used to identify the
owest value causing the interference. Interrogation of the
ulse generator was repeated after each test.
able 1. Demographic and Clinical Characteristics of the
atient Population
en/women, number (%) of tests 151/99 (60.4/39.6)
ge (yrs) 72.2  10.6 (18–85)
eight (cm) 165.8  8.5 (142–188)
eight (kg) 72.4  15.1 (41–135)
acing indications, number (%) of tests
Sinus node dysfunction 99 (39.6)
Atrioventricular block 134 (53.6)
Sinus node dysfunction and
atrioventricular block
11 (4.4)
Other 6 (2.4)
ide of implant, number (%) of tests
Left 221 (88.4)
Right 29 (11.6)
ears of implant, number (%) of tests
1984–1994 16 (6.4)
1995–1999 83 (33.2)
2000–2004 151 (60.4)
nless specified otherwise, data are expressed as the mean value  SD (range).
able 2. Electrocardiographic and Pacing Variables
urface electrocardiogram, number (%) of
tests
Atrial and or ventricular pacing 204 (81.6)
Pacing dependency 133 (53)
Spontaneous rhythm 46 (18.4)
Atrial flutter or fibrillation 47 (18.8)
acing mode, number (%) of tests
DDD(R) 164 (65.6)
DDI(R) 25 (10)
AAI(R) 4 (1.6)
VVI(R) 47 (18.8)
VDD(R) 10 (4)
ensing configuration, number (%) of tests
Bipolar 153 (61.2)
Unipolar 52 (20.8)
Bipolar combined with unipolar 45 (18)
trial sensitivity (mV)
Bipolar (n  165) 0.60  0.27 (0.10–3.0)
Unipolar (n  38) 1.35  0.21 (0.40–1.20)
entricular sensitivity (mV)
Bipolar (n  163) 2.54  0.75 (1.0–5.6)
Unipolar (n  83) 2.60  0.83 (1.0–8.0)nless specified otherwise, data are expressed as the mean value  SD (range).able 3. Pacemaker Models Tested
Manufacturer
Single-
Chamber n
Dual-
Chamber n
iotronik (6) ACTROS DR 1
AXIOS SLR 3
DROMOS DR 1
PHYLOS DR 1
la Medical (56) 112 2 213 11
113 1 230 1
133 1 233 12
4621 1 2550 2
6004 2
6234 8
7034 3
7234 5
7334 7
uidant (43) 972 1
1270 2
1274 13
1280 15
1298 12
ntermedics (4) 291-09 1 292-07 1
292-09 1
293-03 1
edtronic (67) 701 SR 1 303 1
8423 1 701 VDD 1
8960 3 706 2
731 23
733 3
906 1
931 7
7005 1
7085 1
7107 1
7940 1
7941 1
7950 2
7952 1
7960 6
7961 1
7962 7
7966 1
8948 1
acesetter (5) 242-6 1 283 1
2010 2
2011 1
t. Jude (47) 2400 3 2364 8
5130 1 5230 1
5172 1 5330 13
5346 9
5376 9
5430 2
orin (5) MINIOR 100 1 MINISWING DR1 1
ELECT D 2
LIVING 1
electronics (1) 1256 1
itatron (16) 530 1 620 2
611 1 640 1
800 1
900 E 7
9000 2
C60 1
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ith the mean value  SD and range.
ESULTS
total of 250 tests were performed in 245 patients, five of
hom had a second test after pulse generator replacement
or battery depletion. The results are shown in Tables 1, 2,
, and 4. Interference was observed in four (1.6%) of 250
ests. A mode switch from DDD to DOO pacing was
ecorded during the test in three patients with unipolar
rogramming. Transient, asymptomatic, asynchronous
ual-chamber pacing was recorded in two patients, one with
nipolar atrial and ventricular sensing (Medtronic model
31) and the other with atrial unipolar sensing combined
ith bipolar ventricular sensing (Guidant model 1280). In a
hird patient, a switch to the asynchronous mode was
ollowed by pacing inhibition (Fig. 2), resulting in complete
trioventricular (AV) block with profound bradycardia and
ightheadedness (Medtronic model 7960). The lowest value
nducing the mode switch was 45 T. A mode switch was
ecorded in none of 153 tests of systems programmed in
oth atrial and ventricular bipolar sensing configuration,
lthough during one test, transient ventricular pacing with a
horter than programmed AV delay was observed. This
able 4. Details of the Positive Tests
est number 94
acing indication AVB
ide of implant Right
anufacturer Medtronic
odel 7960
ear of implant 1997
acing mode DDD
ermanent ventricular pacing Yes
acing dependency Yes
trial sensing polarity Unipolar
trial sensitivity (mV) 0.50
entricular sensing polarity Unipolar
entricular sensitivity (mV) 2.80
lectrocardiogram DOO pacing inhibition
Interaction with AutoCapture algorithm.igure 2. Testing of Medtronic model 7960. Continuous recording showing paci
DD pacing resumed when exposure to the magnetic field was interrupted (arffect was caused by an interaction between the extracardiac
ignals and a specific algorithm used to confirm ventricular
apture on a beat-by-beat basis. Bipolar atrial sensing at
.75 mV was associated with bipolar ventricular sensing at 2
V (St. Jude Medical, model 5376, AutoCapture). On
ost-test interrogation, reprogramming of no pulse gener-
tor was observed.
ISCUSSION
nterference by electrical appliances generating 50- or
0-Hz electrical or magnetic fields in close or direct contact
ith cardiac pacemakers is a known potential hazard (5).
he main risk factors include device sensitivity, distance
rom the source of magnetic field, and field strength and
rientation. In several clinical studies, the characteristics of
he source of interference were poorly detailed or not
onitored, and electrical and magnetic fields were often
ombined. Reprogramming of the sensitivity settings before
esting, and variations in the exposure parameters lead to
nder- or overestimation of risks and consequences of
nterference. To our knowledge, a single clinical study has
reviously examined the risk of interference by magnetic
elds. The fields were generated by 400-kV outdoor power
lant substations located along roads. Interference was
96 161 180
AVB AVB AVB
Left Left Left
St. Jude Guidant Medtronic
5376 1280 731
2003 2001 2000
DDD DDD DDD
No Yes Yes
No Yes Yes
Bipolar Unipolar Unipolar
0.75 0.50 0.50
Bipolar Bipolar Unipolar
2.00 2.50 2.80
Automatic threshold test* DOO DOOng inhibition and complete atrioventricular block during exposure. Normal
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Magnetic Field and Cardiac Pacemakers March 15, 2005:896–900bserved in one of 15 patients tested at the highest unipolar
evice sensitivity (3). The exposure system used in our study
enerated a continuously monitored, pure magnetic field, in
he absence of any other electrical field. This system had
een evaluated in preliminary tests with a 50-T magnetic
eld, at 50- and 60-Hz frequencies (6). In our protocol, the
0-Hz frequency was the same as that of the European
istribution of electricity, and the 100-T flux density was
t the recommended safety level for public exposure at 50
z (4). The simulation of the geometric effect in the field
as included by orienting the device parallel or perpendic-
lar to the gates. Implanted pacing systems form induction
oops within which interference voltages may be induced by
ime-varying magnetic fields. In vitro studies have shown
nterference thresholds between 552 and 16 T (root mean
quare) for magnetic fields at frequencies between 10 and
50 Hz (2).
Numerical simulations in millimeter-resolution, hetero-
eneous human body models have been performed to study
he interference by 60-Hz magnetic fields with implanted
nipolar pacemakers. Approximations derived from Fara-
ay’s law underscore the complexities of the induced current
owing through the human body, the length and placement
f the leads with respect to the direction of the magnetic
ow, and the inhomogeneous conductivity. Both the model
nd the input resistance of the pacemaker amplifier play
ritical roles in the results of these simulations. Estimated
MI thresholds under “worst case scenarios” were 40 T
or atrial electrodes at a sensitivity setting of 0.25 mV and
40 T for ventricular electrodes at a setting of 0.75 mV
1). According to Faraday’s law of induction, a left-sided
nipolar permanent pacemaker is considered the most
ensitive. In this configuration, the lead forms the largest
nductive area, a semi-circular area 225 cm2, into which a
agnetic field can induce a voltage. In bipolar systems, it
as estimated that the field must be 17-fold larger to
roduce the same effect (7). The bipolar sensing configura-
ion is the most protective against EMI. In recent pace-
aker models, bipolar sensing is combined with self-
djustments enabling the settings of lower sensitivity levels
han usual or nominal.
Our study shows a low incidence of interference by a
igh-density magnetic field in patients tested during routine
ollow-up visits, without changes in the programmed sen-
itivity settings or other pacing parameters made before the
est. No interference was shown with bipolar programming,
xcept for a clinically nonsignificant interaction with a
pecific capture threshold algorithm. In patients with unipo-
ar sensing programming, the interference can cause sus-
ained asynchronous mode reversion and pacing inhibition.
7herefore, the risk of interference by a 50-Hz/100-T
agnetic field appears negligible in patients with bipolar
ensing programming. AutoCapture function, which may
e sensitive to EMI, should be disabled in patients who
ork in such environments. These clinical observations will
elp establish the specific limits of exposure to magnetic
elds in patients with implanted pacemakers.
tudy limitations. Continuous marker channel and intra-
ardiac electrogram recordings allow a more accurate anal-
sis of pacemaker behavior. These recordings were not used,
ecause, in a preliminary study, direct interference by the
agnetic field on the telemetry frequently interrupted the
ata transmission. Therefore, minor abnormalities on the
urface ECG may have been missed.
onclusions. Magnetic fields pulsed at power frequency
aused an intermittent mode switch or pacing inhibition in
small percentage of patients with permanent pacemakers
rogrammed in the unipolar sensing configuration. No
evice reprogramming was observed in this study. The
verall incidence of interference was low with typical device
rogramming.
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